Lyophilized Injectable Drugs Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By Type of Packaging (Point-of-Care Reconstitution, Specialty Packaging and Single-Use Vials); Type of Delivery (Multi-Step Devices, Prefilled Diluent Syringes, Proprietary Reconstitution Devices, and Single-Step Devices); Indication (Autoimmune Diseases, Infectious Diseases, Metabolic Conditions, and Other Indications); End User (Ambulatory Surgical Centers, Hospitals, Specialty Clinics, and Other End Users), and Geography
Report Code: TIPRE00004411 No. of Pages: 150 Category: Pharmaceuticals Status: Upcoming
MARKET INTRODUCTION
Lyophilization is also known as freeze-drying. It is a process of isolating a solid substance from solution by freezing the solution and evaporating it under vacuum. Lyophilized products are known to have a better shelf life and hence are preferred other than the traditional drugs being used. Lyophilization is commonly used for the preservation of compounds such as biologics, proteins, antibodies, blood plasma, enzymes, microorganisms, parenterals, diagnostic reagents, vaccines, and nutraceuticals.
MARKET DYNAMICS
The lyophilized injectable drugs market is anticipated to grow in the forecast, the rising prevalence of metabolic as well as cardiac diseases and the awareness regarding the benefits of lyophilized drugs. In addition, stringent regulations laid by the government bodies is expected to offer significant growth opportunities in the market during the forecast period.
MARKET SCOPE
The "Global Lyophilized Injectable Drugs Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of lyophilized injectable drugs market with detailed market segmentation by type of packaging, type of delivery, indication, end user, and geography. The global lyophilized injectable drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading lyophilized injectable drugs market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global lyophilized injectable drugs market is segmented on the basis of type of packaging, type of delivery, indication, and end user. Based on type of packaging the market is classified as, point-of-care reconstitution, specialty packaging and single-use vials. The lyophilized injectable drugs market is categorized based on type of delivery such as, multi-step devices, prefilled diluent syringes, proprietary reconstitution devices, and single-step devices. Based on indication, the market is categorized as, autoimmune diseases, infectious diseases, metabolic conditions, and other indications. Similarly, based on end user, the lyophilized injectable drugs market is categorized as, ambulatory surgical centers, hospitals, specialty clinics, and other end users.REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global lyophilized injectable drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The lyophilized injectable drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting lyophilized injectable drugs market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the lyophilized injectable drugs market in these regions.
MARKET PLAYERS
The reports cover key developments in the lyophilized injectable drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from lyophilized injectable drugs market are anticipated to lucrative growth opportunities in the future with the rising demand for lyophilized injectable drugs market in the global market. Below mentioned is the list of few companies engaged in the lyophilized injectable drugs market.
The report also includes the profiles of key lyophilized injectable drugs market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Lyophilization is also known as freeze-drying. It is a process of isolating a solid substance from solution by freezing the solution and evaporating it under vacuum. Lyophilized products are known to have a better shelf life and hence are preferred other than the traditional drugs being used. Lyophilization is commonly used for the preservation of compounds such as biologics, proteins, antibodies, blood plasma, enzymes, microorganisms, parenterals, diagnostic reagents, vaccines, and nutraceuticals.
MARKET DYNAMICS
The lyophilized injectable drugs market is anticipated to grow in the forecast, the rising prevalence of metabolic as well as cardiac diseases and the awareness regarding the benefits of lyophilized drugs. In addition, stringent regulations laid by the government bodies is expected to offer significant growth opportunities in the market during the forecast period.
MARKET SCOPE
The "Global Lyophilized Injectable Drugs Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of lyophilized injectable drugs market with detailed market segmentation by type of packaging, type of delivery, indication, end user, and geography. The global lyophilized injectable drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading lyophilized injectable drugs market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global lyophilized injectable drugs market is segmented on the basis of type of packaging, type of delivery, indication, and end user. Based on type of packaging the market is classified as, point-of-care reconstitution, specialty packaging and single-use vials. The lyophilized injectable drugs market is categorized based on type of delivery such as, multi-step devices, prefilled diluent syringes, proprietary reconstitution devices, and single-step devices. Based on indication, the market is categorized as, autoimmune diseases, infectious diseases, metabolic conditions, and other indications. Similarly, based on end user, the lyophilized injectable drugs market is categorized as, ambulatory surgical centers, hospitals, specialty clinics, and other end users.REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global lyophilized injectable drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The lyophilized injectable drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting lyophilized injectable drugs market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the lyophilized injectable drugs market in these regions.
MARKET PLAYERS
The reports cover key developments in the lyophilized injectable drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from lyophilized injectable drugs market are anticipated to lucrative growth opportunities in the future with the rising demand for lyophilized injectable drugs market in the global market. Below mentioned is the list of few companies engaged in the lyophilized injectable drugs market.
The report also includes the profiles of key lyophilized injectable drugs market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Albany Molecular Research Inc.
- BD
- Burrard Pharmaceuticals
- Cirondrugs
- CordenPharma International
- Emergent BioSolutions Inc.
- Jubilant HollisterStier LLC
- Mylan N.V.
- Recipharm AB (publ)
- S. G. Biopharm Pvt. Ltd.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Lyophilized Injectable Drugs Market - By Type of Packaging
1.3.2 Lyophilized Injectable Drugs Market - By Type of Delivery
1.3.3 Lyophilized Injectable Drugs Market - By Indication
1.3.4 Lyophilized Injectable Drugs Market - By End User
1.3.5 Lyophilized Injectable Drugs Market - By Region
1.3.5.1 by Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. LYOPHILIZED INJECTABLE DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. LYOPHILIZED INJECTABLE DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. LYOPHILIZED INJECTABLE DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. LYOPHILIZED INJECTABLE DRUGS - GLOBAL MARKET OVERVIEW
6.2. LYOPHILIZED INJECTABLE DRUGS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. LYOPHILIZED INJECTABLE DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - TYPE OF PACKAGING
7.1. OVERVIEW
7.2. TYPE OF PACKAGING MARKET FORECASTS AND ANALYSIS
7.3. POINT-OF-CARE RECONSTITUTION
7.3.1. Overview
7.3.2. Point-of-Care Reconstitution Market Forecast and Analysis
7.4. SPECIALTY PACKAGING
7.4.1. Overview
7.4.2. Specialty Packaging Market Forecast and Analysis
7.5. SINGLE-USE VIALS
7.5.1. Overview
7.5.2. Single-Use Vials Market Forecast and Analysis
8. LYOPHILIZED INJECTABLE DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - TYPE OF DELIVERY
8.1. OVERVIEW
8.2. TYPE OF DELIVERY MARKET FORECASTS AND ANALYSIS
8.3. MULTI-STEP DEVICES
8.3.1. Overview
8.3.2. Multi-Step Devices Market Forecast and Analysis
8.4. PREFILLED DILUENT SYRINGES
8.4.1. Overview
8.4.2. Prefilled Diluent Syringes Market Forecast and Analysis
8.5. PROPRIETARY RECONSTITUTION DEVICES
8.5.1. Overview
8.5.2. Proprietary Reconstitution Devices Market Forecast and Analysis
8.6. SINGLE-STEP DEVICES
8.6.1. Overview
8.6.2. Single-Step Devices Market Forecast and Analysis
9. LYOPHILIZED INJECTABLE DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - INDICATION
9.1. OVERVIEW
9.2. INDICATION MARKET FORECASTS AND ANALYSIS
9.3. AUTOIMMUNE DISEASES
9.3.1. Overview
9.3.2. Autoimmune Diseases Market Forecast and Analysis
9.4. INFECTIOUS DISEASES
9.4.1. Overview
9.4.2. Infectious Diseases Market Forecast and Analysis
9.5. METABOLIC CONDITIONS
9.5.1. Overview
9.5.2. Metabolic Conditions Market Forecast and Analysis
9.6. OTHER INDIACATIONS
9.6.1. Overview
9.6.2. Other Indications Market Forecast and Analysis
10. LYOPHILIZED INJECTABLE DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. AMBULATORY SURGICAL CENTERS
10.3.1. Overview
10.3.2. Ambulatory Surgical Centers Market Forecast and Analysis
10.4. HOSPITALS
10.4.1. Overview
10.4.2. Hospitals Market Forecast and Analysis
10.5. SPECIALTY CLINICS
10.5.1. Overview
10.5.2. Specialty Clinics Market Forecast and Analysis
10.6. OTHER END USERS
10.6.1. Overview
10.6.2. Other End Users Market Forecast and Analysis
11. LYOPHILIZED INJECTABLE DRUGS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Lyophilized Injectable Drugs Market Overview
11.1.2 North America Lyophilized Injectable Drugs Market Forecasts and Analysis
11.1.3 North America Lyophilized Injectable Drugs Market Forecasts and Analysis - By Type of Packaging
11.1.4 North America Lyophilized Injectable Drugs Market Forecasts and Analysis - By Type of Delivery
11.1.5 North America Lyophilized Injectable Drugs Market Forecasts and Analysis - By Indication
11.1.6 North America Lyophilized Injectable Drugs Market Forecasts and Analysis - By End User
11.1.7 North America Lyophilized Injectable Drugs Market Forecasts and Analysis - By Countries
11.1.7.1 United States Lyophilized Injectable Drugs Market
11.1.7.1.1 United States Lyophilized Injectable Drugs Market by Type of Packaging
11.1.7.1.2 United States Lyophilized Injectable Drugs Market by Type of Delivery
11.1.7.1.3 United States Lyophilized Injectable Drugs Market by Indication
11.1.7.1.4 United States Lyophilized Injectable Drugs Market by End User
11.1.7.2 Canada Lyophilized Injectable Drugs Market
11.1.7.2.1 Canada Lyophilized Injectable Drugs Market by Type of Packaging
11.1.7.2.2 Canada Lyophilized Injectable Drugs Market by Type of Delivery
11.1.7.2.3 Canada Lyophilized Injectable Drugs Market by Indication
11.1.7.2.4 Canada Lyophilized Injectable Drugs Market by End User
11.1.7.3 Mexico Lyophilized Injectable Drugs Market
11.1.7.3.1 Mexico Lyophilized Injectable Drugs Market by Type of Packaging
11.1.7.3.2 Mexico Lyophilized Injectable Drugs Market by Type of Delivery
11.1.7.3.3 Mexico Lyophilized Injectable Drugs Market by Indication
11.1.7.3.4 Mexico Lyophilized Injectable Drugs Market by End User
11.2. EUROPE
11.2.1 Europe Lyophilized Injectable Drugs Market Overview
11.2.2 Europe Lyophilized Injectable Drugs Market Forecasts and Analysis
11.2.3 Europe Lyophilized Injectable Drugs Market Forecasts and Analysis - By Type of Packaging
11.2.4 Europe Lyophilized Injectable Drugs Market Forecasts and Analysis - By Type of Delivery
11.2.5 Europe Lyophilized Injectable Drugs Market Forecasts and Analysis - By Indication
11.2.6 Europe Lyophilized Injectable Drugs Market Forecasts and Analysis - By End User
11.2.7 Europe Lyophilized Injectable Drugs Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Lyophilized Injectable Drugs Market
11.2.7.1.1 Germany Lyophilized Injectable Drugs Market by Type of Packaging
11.2.7.1.2 Germany Lyophilized Injectable Drugs Market by Type of Delivery
11.2.7.1.3 Germany Lyophilized Injectable Drugs Market by Indication
11.2.7.1.4 Germany Lyophilized Injectable Drugs Market by End User
11.2.7.2 France Lyophilized Injectable Drugs Market
11.2.7.2.1 France Lyophilized Injectable Drugs Market by Type of Packaging
11.2.7.2.2 France Lyophilized Injectable Drugs Market by Type of Delivery
11.2.7.2.3 France Lyophilized Injectable Drugs Market by Indication
11.2.7.2.4 France Lyophilized Injectable Drugs Market by End User
11.2.7.3 Italy Lyophilized Injectable Drugs Market
11.2.7.3.1 Italy Lyophilized Injectable Drugs Market by Type of Packaging
11.2.7.3.2 Italy Lyophilized Injectable Drugs Market by Type of Delivery
11.2.7.3.3 Italy Lyophilized Injectable Drugs Market by Indication
11.2.7.3.4 Italy Lyophilized Injectable Drugs Market by End User
11.2.7.4 Spain Lyophilized Injectable Drugs Market
11.2.7.4.1 Spain Lyophilized Injectable Drugs Market by Type of Packaging
11.2.7.4.2 Spain Lyophilized Injectable Drugs Market by Type of Delivery
11.2.7.4.3 Spain Lyophilized Injectable Drugs Market by Indication
11.2.7.4.4 Spain Lyophilized Injectable Drugs Market by End User
11.2.7.5 United Kingdom Lyophilized Injectable Drugs Market
11.2.7.5.1 United Kingdom Lyophilized Injectable Drugs Market by Type of Packaging
11.2.7.5.2 United Kingdom Lyophilized Injectable Drugs Market by Type of Delivery
11.2.7.5.3 United Kingdom Lyophilized Injectable Drugs Market by Indication
11.2.7.5.4 United Kingdom Lyophilized Injectable Drugs Market by End User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Lyophilized Injectable Drugs Market Overview
11.3.2 Asia-Pacific Lyophilized Injectable Drugs Market Forecasts and Analysis
11.3.3 Asia-Pacific Lyophilized Injectable Drugs Market Forecasts and Analysis - By Type of Packaging
11.3.4 Asia-Pacific Lyophilized Injectable Drugs Market Forecasts and Analysis - By Type of Delivery
11.3.5 Asia-Pacific Lyophilized Injectable Drugs Market Forecasts and Analysis - By Indication
11.3.6 Asia-Pacific Lyophilized Injectable Drugs Market Forecasts and Analysis - By End User
11.3.7 Asia-Pacific Lyophilized Injectable Drugs Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Lyophilized Injectable Drugs Market
11.3.7.1.1 Australia Lyophilized Injectable Drugs Market by Type of Packaging
11.3.7.1.2 Australia Lyophilized Injectable Drugs Market by Type of Delivery
11.3.7.1.3 Australia Lyophilized Injectable Drugs Market by Indication
11.3.7.1.4 Australia Lyophilized Injectable Drugs Market by End User
11.3.7.2 China Lyophilized Injectable Drugs Market
11.3.7.2.1 China Lyophilized Injectable Drugs Market by Type of Packaging
11.3.7.2.2 China Lyophilized Injectable Drugs Market by Type of Delivery
11.3.7.2.3 China Lyophilized Injectable Drugs Market by Indication
11.3.7.2.4 China Lyophilized Injectable Drugs Market by End User
11.3.7.3 India Lyophilized Injectable Drugs Market
11.3.7.3.1 India Lyophilized Injectable Drugs Market by Type of Packaging
11.3.7.3.2 India Lyophilized Injectable Drugs Market by Type of Delivery
11.3.7.3.3 India Lyophilized Injectable Drugs Market by Indication
11.3.7.3.4 India Lyophilized Injectable Drugs Market by End User
11.3.7.4 Japan Lyophilized Injectable Drugs Market
11.3.7.4.1 Japan Lyophilized Injectable Drugs Market by Type of Packaging
11.3.7.4.2 Japan Lyophilized Injectable Drugs Market by Type of Delivery
11.3.7.4.3 Japan Lyophilized Injectable Drugs Market by Indication
11.3.7.4.4 Japan Lyophilized Injectable Drugs Market by End User
11.3.7.5 South Korea Lyophilized Injectable Drugs Market
11.3.7.5.1 South Korea Lyophilized Injectable Drugs Market by Type of Packaging
11.3.7.5.2 South Korea Lyophilized Injectable Drugs Market by Type of Delivery
11.3.7.5.3 South Korea Lyophilized Injectable Drugs Market by Indication
11.3.7.5.4 South Korea Lyophilized Injectable Drugs Market by End User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Lyophilized Injectable Drugs Market Overview
11.4.2 Middle East and Africa Lyophilized Injectable Drugs Market Forecasts and Analysis
11.4.3 Middle East and Africa Lyophilized Injectable Drugs Market Forecasts and Analysis - By Type of Packaging
11.4.4 Middle East and Africa Lyophilized Injectable Drugs Market Forecasts and Analysis - By Type of Delivery
11.4.5 Middle East and Africa Lyophilized Injectable Drugs Market Forecasts and Analysis - By Indication
11.4.6 Middle East and Africa Lyophilized Injectable Drugs Market Forecasts and Analysis - By End User
11.4.7 Middle East and Africa Lyophilized Injectable Drugs Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Lyophilized Injectable Drugs Market
11.4.7.1.1 South Africa Lyophilized Injectable Drugs Market by Type of Packaging
11.4.7.1.2 South Africa Lyophilized Injectable Drugs Market by Type of Delivery
11.4.7.1.3 South Africa Lyophilized Injectable Drugs Market by Indication
11.4.7.1.4 South Africa Lyophilized Injectable Drugs Market by End User
11.4.7.2 Saudi Arabia Lyophilized Injectable Drugs Market
11.4.7.2.1 Saudi Arabia Lyophilized Injectable Drugs Market by Type of Packaging
11.4.7.2.2 Saudi Arabia Lyophilized Injectable Drugs Market by Type of Delivery
11.4.7.2.3 Saudi Arabia Lyophilized Injectable Drugs Market by Indication
11.4.7.2.4 Saudi Arabia Lyophilized Injectable Drugs Market by End User
11.4.7.3 U.A.E Lyophilized Injectable Drugs Market
11.4.7.3.1 U.A.E Lyophilized Injectable Drugs Market by Type of Packaging
11.4.7.3.2 U.A.E Lyophilized Injectable Drugs Market by Type of Delivery
11.4.7.3.3 U.A.E Lyophilized Injectable Drugs Market by Indication
11.4.7.3.4 U.A.E Lyophilized Injectable Drugs Market by End User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Lyophilized Injectable Drugs Market Overview
11.5.2 South and Central America Lyophilized Injectable Drugs Market Forecasts and Analysis
11.5.3 South and Central America Lyophilized Injectable Drugs Market Forecasts and Analysis - By Type of Packaging
11.5.4 South and Central America Lyophilized Injectable Drugs Market Forecasts and Analysis - By Type of Delivery
11.5.5 South and Central America Lyophilized Injectable Drugs Market Forecasts and Analysis - By Indication
11.5.6 South and Central America Lyophilized Injectable Drugs Market Forecasts and Analysis - By End User
11.5.7 South and Central America Lyophilized Injectable Drugs Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Lyophilized Injectable Drugs Market
11.5.7.1.1 Brazil Lyophilized Injectable Drugs Market by Type of Packaging
11.5.7.1.2 Brazil Lyophilized Injectable Drugs Market by Type of Delivery
11.5.7.1.3 Brazil Lyophilized Injectable Drugs Market by Indication
11.5.7.1.4 Brazil Lyophilized Injectable Drugs Market by End User
11.5.7.2 Argentina Lyophilized Injectable Drugs Market
11.5.7.2.1 Argentina Lyophilized Injectable Drugs Market by Type of Packaging
11.5.7.2.2 Argentina Lyophilized Injectable Drugs Market by Type of Delivery
11.5.7.2.3 Argentina Lyophilized Injectable Drugs Market by Indication
11.5.7.2.4 Argentina Lyophilized Injectable Drugs Market by End User
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. LYOPHILIZED INJECTABLE DRUGS MARKET, KEY COMPANY PROFILES
13.1. ALBANY MOLECULAR RESEARCH INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. BD
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. BURRARD PHARMACEUTICALS
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. CIRONDRUGS
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. CORDENPHARMA INTERNATIONAL
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. EMERGENT BIOSOLUTIONS INC.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. JUBILANT HOLLISTERSTIER LLC
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. MYLAN N.V.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. RECIPHARM AB (PUBL)
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. S. G. BIOPHARM PVT. LTD.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Lyophilized Injectable Drugs Market - By Type of Packaging
1.3.2 Lyophilized Injectable Drugs Market - By Type of Delivery
1.3.3 Lyophilized Injectable Drugs Market - By Indication
1.3.4 Lyophilized Injectable Drugs Market - By End User
1.3.5 Lyophilized Injectable Drugs Market - By Region
1.3.5.1 by Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. LYOPHILIZED INJECTABLE DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. LYOPHILIZED INJECTABLE DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. LYOPHILIZED INJECTABLE DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. LYOPHILIZED INJECTABLE DRUGS - GLOBAL MARKET OVERVIEW
6.2. LYOPHILIZED INJECTABLE DRUGS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. LYOPHILIZED INJECTABLE DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - TYPE OF PACKAGING
7.1. OVERVIEW
7.2. TYPE OF PACKAGING MARKET FORECASTS AND ANALYSIS
7.3. POINT-OF-CARE RECONSTITUTION
7.3.1. Overview
7.3.2. Point-of-Care Reconstitution Market Forecast and Analysis
7.4. SPECIALTY PACKAGING
7.4.1. Overview
7.4.2. Specialty Packaging Market Forecast and Analysis
7.5. SINGLE-USE VIALS
7.5.1. Overview
7.5.2. Single-Use Vials Market Forecast and Analysis
8. LYOPHILIZED INJECTABLE DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - TYPE OF DELIVERY
8.1. OVERVIEW
8.2. TYPE OF DELIVERY MARKET FORECASTS AND ANALYSIS
8.3. MULTI-STEP DEVICES
8.3.1. Overview
8.3.2. Multi-Step Devices Market Forecast and Analysis
8.4. PREFILLED DILUENT SYRINGES
8.4.1. Overview
8.4.2. Prefilled Diluent Syringes Market Forecast and Analysis
8.5. PROPRIETARY RECONSTITUTION DEVICES
8.5.1. Overview
8.5.2. Proprietary Reconstitution Devices Market Forecast and Analysis
8.6. SINGLE-STEP DEVICES
8.6.1. Overview
8.6.2. Single-Step Devices Market Forecast and Analysis
9. LYOPHILIZED INJECTABLE DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - INDICATION
9.1. OVERVIEW
9.2. INDICATION MARKET FORECASTS AND ANALYSIS
9.3. AUTOIMMUNE DISEASES
9.3.1. Overview
9.3.2. Autoimmune Diseases Market Forecast and Analysis
9.4. INFECTIOUS DISEASES
9.4.1. Overview
9.4.2. Infectious Diseases Market Forecast and Analysis
9.5. METABOLIC CONDITIONS
9.5.1. Overview
9.5.2. Metabolic Conditions Market Forecast and Analysis
9.6. OTHER INDIACATIONS
9.6.1. Overview
9.6.2. Other Indications Market Forecast and Analysis
10. LYOPHILIZED INJECTABLE DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. AMBULATORY SURGICAL CENTERS
10.3.1. Overview
10.3.2. Ambulatory Surgical Centers Market Forecast and Analysis
10.4. HOSPITALS
10.4.1. Overview
10.4.2. Hospitals Market Forecast and Analysis
10.5. SPECIALTY CLINICS
10.5.1. Overview
10.5.2. Specialty Clinics Market Forecast and Analysis
10.6. OTHER END USERS
10.6.1. Overview
10.6.2. Other End Users Market Forecast and Analysis
11. LYOPHILIZED INJECTABLE DRUGS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Lyophilized Injectable Drugs Market Overview
11.1.2 North America Lyophilized Injectable Drugs Market Forecasts and Analysis
11.1.3 North America Lyophilized Injectable Drugs Market Forecasts and Analysis - By Type of Packaging
11.1.4 North America Lyophilized Injectable Drugs Market Forecasts and Analysis - By Type of Delivery
11.1.5 North America Lyophilized Injectable Drugs Market Forecasts and Analysis - By Indication
11.1.6 North America Lyophilized Injectable Drugs Market Forecasts and Analysis - By End User
11.1.7 North America Lyophilized Injectable Drugs Market Forecasts and Analysis - By Countries
11.1.7.1 United States Lyophilized Injectable Drugs Market
11.1.7.1.1 United States Lyophilized Injectable Drugs Market by Type of Packaging
11.1.7.1.2 United States Lyophilized Injectable Drugs Market by Type of Delivery
11.1.7.1.3 United States Lyophilized Injectable Drugs Market by Indication
11.1.7.1.4 United States Lyophilized Injectable Drugs Market by End User
11.1.7.2 Canada Lyophilized Injectable Drugs Market
11.1.7.2.1 Canada Lyophilized Injectable Drugs Market by Type of Packaging
11.1.7.2.2 Canada Lyophilized Injectable Drugs Market by Type of Delivery
11.1.7.2.3 Canada Lyophilized Injectable Drugs Market by Indication
11.1.7.2.4 Canada Lyophilized Injectable Drugs Market by End User
11.1.7.3 Mexico Lyophilized Injectable Drugs Market
11.1.7.3.1 Mexico Lyophilized Injectable Drugs Market by Type of Packaging
11.1.7.3.2 Mexico Lyophilized Injectable Drugs Market by Type of Delivery
11.1.7.3.3 Mexico Lyophilized Injectable Drugs Market by Indication
11.1.7.3.4 Mexico Lyophilized Injectable Drugs Market by End User
11.2. EUROPE
11.2.1 Europe Lyophilized Injectable Drugs Market Overview
11.2.2 Europe Lyophilized Injectable Drugs Market Forecasts and Analysis
11.2.3 Europe Lyophilized Injectable Drugs Market Forecasts and Analysis - By Type of Packaging
11.2.4 Europe Lyophilized Injectable Drugs Market Forecasts and Analysis - By Type of Delivery
11.2.5 Europe Lyophilized Injectable Drugs Market Forecasts and Analysis - By Indication
11.2.6 Europe Lyophilized Injectable Drugs Market Forecasts and Analysis - By End User
11.2.7 Europe Lyophilized Injectable Drugs Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Lyophilized Injectable Drugs Market
11.2.7.1.1 Germany Lyophilized Injectable Drugs Market by Type of Packaging
11.2.7.1.2 Germany Lyophilized Injectable Drugs Market by Type of Delivery
11.2.7.1.3 Germany Lyophilized Injectable Drugs Market by Indication
11.2.7.1.4 Germany Lyophilized Injectable Drugs Market by End User
11.2.7.2 France Lyophilized Injectable Drugs Market
11.2.7.2.1 France Lyophilized Injectable Drugs Market by Type of Packaging
11.2.7.2.2 France Lyophilized Injectable Drugs Market by Type of Delivery
11.2.7.2.3 France Lyophilized Injectable Drugs Market by Indication
11.2.7.2.4 France Lyophilized Injectable Drugs Market by End User
11.2.7.3 Italy Lyophilized Injectable Drugs Market
11.2.7.3.1 Italy Lyophilized Injectable Drugs Market by Type of Packaging
11.2.7.3.2 Italy Lyophilized Injectable Drugs Market by Type of Delivery
11.2.7.3.3 Italy Lyophilized Injectable Drugs Market by Indication
11.2.7.3.4 Italy Lyophilized Injectable Drugs Market by End User
11.2.7.4 Spain Lyophilized Injectable Drugs Market
11.2.7.4.1 Spain Lyophilized Injectable Drugs Market by Type of Packaging
11.2.7.4.2 Spain Lyophilized Injectable Drugs Market by Type of Delivery
11.2.7.4.3 Spain Lyophilized Injectable Drugs Market by Indication
11.2.7.4.4 Spain Lyophilized Injectable Drugs Market by End User
11.2.7.5 United Kingdom Lyophilized Injectable Drugs Market
11.2.7.5.1 United Kingdom Lyophilized Injectable Drugs Market by Type of Packaging
11.2.7.5.2 United Kingdom Lyophilized Injectable Drugs Market by Type of Delivery
11.2.7.5.3 United Kingdom Lyophilized Injectable Drugs Market by Indication
11.2.7.5.4 United Kingdom Lyophilized Injectable Drugs Market by End User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Lyophilized Injectable Drugs Market Overview
11.3.2 Asia-Pacific Lyophilized Injectable Drugs Market Forecasts and Analysis
11.3.3 Asia-Pacific Lyophilized Injectable Drugs Market Forecasts and Analysis - By Type of Packaging
11.3.4 Asia-Pacific Lyophilized Injectable Drugs Market Forecasts and Analysis - By Type of Delivery
11.3.5 Asia-Pacific Lyophilized Injectable Drugs Market Forecasts and Analysis - By Indication
11.3.6 Asia-Pacific Lyophilized Injectable Drugs Market Forecasts and Analysis - By End User
11.3.7 Asia-Pacific Lyophilized Injectable Drugs Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Lyophilized Injectable Drugs Market
11.3.7.1.1 Australia Lyophilized Injectable Drugs Market by Type of Packaging
11.3.7.1.2 Australia Lyophilized Injectable Drugs Market by Type of Delivery
11.3.7.1.3 Australia Lyophilized Injectable Drugs Market by Indication
11.3.7.1.4 Australia Lyophilized Injectable Drugs Market by End User
11.3.7.2 China Lyophilized Injectable Drugs Market
11.3.7.2.1 China Lyophilized Injectable Drugs Market by Type of Packaging
11.3.7.2.2 China Lyophilized Injectable Drugs Market by Type of Delivery
11.3.7.2.3 China Lyophilized Injectable Drugs Market by Indication
11.3.7.2.4 China Lyophilized Injectable Drugs Market by End User
11.3.7.3 India Lyophilized Injectable Drugs Market
11.3.7.3.1 India Lyophilized Injectable Drugs Market by Type of Packaging
11.3.7.3.2 India Lyophilized Injectable Drugs Market by Type of Delivery
11.3.7.3.3 India Lyophilized Injectable Drugs Market by Indication
11.3.7.3.4 India Lyophilized Injectable Drugs Market by End User
11.3.7.4 Japan Lyophilized Injectable Drugs Market
11.3.7.4.1 Japan Lyophilized Injectable Drugs Market by Type of Packaging
11.3.7.4.2 Japan Lyophilized Injectable Drugs Market by Type of Delivery
11.3.7.4.3 Japan Lyophilized Injectable Drugs Market by Indication
11.3.7.4.4 Japan Lyophilized Injectable Drugs Market by End User
11.3.7.5 South Korea Lyophilized Injectable Drugs Market
11.3.7.5.1 South Korea Lyophilized Injectable Drugs Market by Type of Packaging
11.3.7.5.2 South Korea Lyophilized Injectable Drugs Market by Type of Delivery
11.3.7.5.3 South Korea Lyophilized Injectable Drugs Market by Indication
11.3.7.5.4 South Korea Lyophilized Injectable Drugs Market by End User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Lyophilized Injectable Drugs Market Overview
11.4.2 Middle East and Africa Lyophilized Injectable Drugs Market Forecasts and Analysis
11.4.3 Middle East and Africa Lyophilized Injectable Drugs Market Forecasts and Analysis - By Type of Packaging
11.4.4 Middle East and Africa Lyophilized Injectable Drugs Market Forecasts and Analysis - By Type of Delivery
11.4.5 Middle East and Africa Lyophilized Injectable Drugs Market Forecasts and Analysis - By Indication
11.4.6 Middle East and Africa Lyophilized Injectable Drugs Market Forecasts and Analysis - By End User
11.4.7 Middle East and Africa Lyophilized Injectable Drugs Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Lyophilized Injectable Drugs Market
11.4.7.1.1 South Africa Lyophilized Injectable Drugs Market by Type of Packaging
11.4.7.1.2 South Africa Lyophilized Injectable Drugs Market by Type of Delivery
11.4.7.1.3 South Africa Lyophilized Injectable Drugs Market by Indication
11.4.7.1.4 South Africa Lyophilized Injectable Drugs Market by End User
11.4.7.2 Saudi Arabia Lyophilized Injectable Drugs Market
11.4.7.2.1 Saudi Arabia Lyophilized Injectable Drugs Market by Type of Packaging
11.4.7.2.2 Saudi Arabia Lyophilized Injectable Drugs Market by Type of Delivery
11.4.7.2.3 Saudi Arabia Lyophilized Injectable Drugs Market by Indication
11.4.7.2.4 Saudi Arabia Lyophilized Injectable Drugs Market by End User
11.4.7.3 U.A.E Lyophilized Injectable Drugs Market
11.4.7.3.1 U.A.E Lyophilized Injectable Drugs Market by Type of Packaging
11.4.7.3.2 U.A.E Lyophilized Injectable Drugs Market by Type of Delivery
11.4.7.3.3 U.A.E Lyophilized Injectable Drugs Market by Indication
11.4.7.3.4 U.A.E Lyophilized Injectable Drugs Market by End User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Lyophilized Injectable Drugs Market Overview
11.5.2 South and Central America Lyophilized Injectable Drugs Market Forecasts and Analysis
11.5.3 South and Central America Lyophilized Injectable Drugs Market Forecasts and Analysis - By Type of Packaging
11.5.4 South and Central America Lyophilized Injectable Drugs Market Forecasts and Analysis - By Type of Delivery
11.5.5 South and Central America Lyophilized Injectable Drugs Market Forecasts and Analysis - By Indication
11.5.6 South and Central America Lyophilized Injectable Drugs Market Forecasts and Analysis - By End User
11.5.7 South and Central America Lyophilized Injectable Drugs Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Lyophilized Injectable Drugs Market
11.5.7.1.1 Brazil Lyophilized Injectable Drugs Market by Type of Packaging
11.5.7.1.2 Brazil Lyophilized Injectable Drugs Market by Type of Delivery
11.5.7.1.3 Brazil Lyophilized Injectable Drugs Market by Indication
11.5.7.1.4 Brazil Lyophilized Injectable Drugs Market by End User
11.5.7.2 Argentina Lyophilized Injectable Drugs Market
11.5.7.2.1 Argentina Lyophilized Injectable Drugs Market by Type of Packaging
11.5.7.2.2 Argentina Lyophilized Injectable Drugs Market by Type of Delivery
11.5.7.2.3 Argentina Lyophilized Injectable Drugs Market by Indication
11.5.7.2.4 Argentina Lyophilized Injectable Drugs Market by End User
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. LYOPHILIZED INJECTABLE DRUGS MARKET, KEY COMPANY PROFILES
13.1. ALBANY MOLECULAR RESEARCH INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. BD
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. BURRARD PHARMACEUTICALS
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. CIRONDRUGS
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. CORDENPHARMA INTERNATIONAL
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. EMERGENT BIOSOLUTIONS INC.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. JUBILANT HOLLISTERSTIER LLC
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. MYLAN N.V.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. RECIPHARM AB (PUBL)
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. S. G. BIOPHARM PVT. LTD.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies
1. Albany Molecular Research Inc.
2. BD
3. Burrard Pharmaceuticals
4. Cirondrugs
5. CordenPharma International
6. Emergent BioSolutions Inc.
7. Jubilant HollisterStier LLC
8. Mylan N. V.
9. Recipharm AB (publ)
10. S. G. Biopharm Pvt. Ltd.
1. Albany Molecular Research Inc.
2. BD
3. Burrard Pharmaceuticals
4. Cirondrugs
5. CordenPharma International
6. Emergent BioSolutions Inc.
7. Jubilant HollisterStier LLC
8. Mylan N. V.
9. Recipharm AB (publ)
10. S. G. Biopharm Pvt. Ltd.